Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial

1. Duvic, M.
2. Dummer, R.
3. Becker, J.C.
4. Poulalhon, N.
5. Ortiz Romero, P.
6. Grazia Bernengo, M.
7. Lebbé, C.
8. Assaf, C.
9. Squier, M.
10. Williams, D.
11. Marshood, M.
12. Tai, F.
13. Prince, H.M.